Results 171 to 180 of about 21,899 (194)
Some of the next articles are maybe not open access.
The American Journal of Pathology, 2022
Idiopathic pulmonary fibrosis (IPF) is a dramatic disease without cure. The US Food and Drug Administration-approved drugs, pirfenidone and nintedanib, only slow disease progression. The clinical investigation of novel therapeutic approaches for IPF is an unmet clinical need. Nucleotide-binding oligomerization domain-like receptor or NOD-like receptors
Ruben M.L. Colunga Biancatelli +2 more
openaire +2 more sources
Idiopathic pulmonary fibrosis (IPF) is a dramatic disease without cure. The US Food and Drug Administration-approved drugs, pirfenidone and nintedanib, only slow disease progression. The clinical investigation of novel therapeutic approaches for IPF is an unmet clinical need. Nucleotide-binding oligomerization domain-like receptor or NOD-like receptors
Ruben M.L. Colunga Biancatelli +2 more
openaire +2 more sources
Bioorganic & Medicinal Chemistry Letters, 2020
Aberrant activation of NLRP3 inflammasome is present in a subset of acute and chronic inflammatory diseases. The NLRP3 inflammasome has been recognized as an attractive therapeutic target for developing novel and specific anti-inflammatory inhibitors. Cellular structure-activity relationship-guided optimization resulted in the identification of 4-oxo-2-
Yun, Chen +8 more
openaire +2 more sources
Aberrant activation of NLRP3 inflammasome is present in a subset of acute and chronic inflammatory diseases. The NLRP3 inflammasome has been recognized as an attractive therapeutic target for developing novel and specific anti-inflammatory inhibitors. Cellular structure-activity relationship-guided optimization resulted in the identification of 4-oxo-2-
Yun, Chen +8 more
openaire +2 more sources
AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
Nature, 2021Sangjoon Lee, , Yaqiu Wang
exaly
HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation
Science, 2020Venkat Giri Magupalli +2 more
exaly
Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis
Nature Immunology, 2020Elaine F Remmers +2 more
exaly
Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis
Cellular and Molecular Immunology, 2023, Sangjoon Lee
exaly
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Nature Reviews Immunology, 2019Karen V Swanson, Meng Deng
exaly

